Published in Proc Natl Acad Sci U S A on October 01, 1990
Shiga toxins--from cell biology to biomedical applications. Nat Rev Microbiol (2009) 2.19
Retrograde transport pathways utilised by viruses and protein toxins. Virol J (2006) 1.61
Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines. Infect Immun (1996) 1.56
Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection. Infect Immun (2002) 1.49
Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications. Infect Immun (2005) 1.38
Production and characterization of protective human antibodies against Shiga toxin 1. Infect Immun (2002) 1.23
Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. J Infect Dis (2008) 1.16
Interaction of verotoxin 2e with pig intestine. Infect Immun (1996) 1.08
The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1. Proc Natl Acad Sci U S A (1995) 0.98
Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide. Infect Immun (2010) 0.96
Shiga toxin interaction with human intestinal epithelium. Toxins (Basel) (2011) 0.96
Ribosome-inactivating proteins: potent poisons and molecular tools. Virulence (2013) 0.94
Diversity and impact of prokaryotic toxins on aquatic environments: a review. Toxins (Basel) (2010) 0.94
Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin. Infect Immun (1995) 0.90
"Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery? Adv Drug Deliv Rev (2007) 0.89
Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib. Front Cell Infect Microbiol (2012) 0.88
Shiga toxin pathogenesis: kidney complications and renal failure. Curr Top Microbiol Immunol (2012) 0.86
A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles. PLoS Pathog (2015) 0.84
Glycolipid modification of alpha 2 interferon binding. Sequence similarity between the alpha 2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit. Biochem J (1992) 0.81
Localization of potential binding sites for the edema disease verotoxin (VT2e) in pigs. Can J Vet Res (1998) 0.81
Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells. Glycoconj J (1999) 0.80
Mouse toxicity and cytokine release by verotoxin 1 B subunit mutants. Infect Immun (2001) 0.79
Shiga Toxins as Multi-Functional Proteins: Induction of Host Cellular Stress Responses, Role in Pathogenesis and Therapeutic Applications. Toxins (Basel) (2016) 0.78
Distribution of Gb(3) Immunoreactivity in the Mouse Central Nervous System. Toxins (Basel) (2010) 0.78
Verotoxin-1 treatment or manipulation of its receptor globotriaosylceramide (gb3) for reversal of multidrug resistance to cancer chemotherapy. Toxins (Basel) (2010) 0.77
Interaction of the verotoxin 1B subunit with soluble aminodeoxy analogues of globotriaosyl ceramides. Biochem J (2002) 0.76
Effects of Shiga toxin type 2 on maternal and fetal status in rats in the early stage of pregnancy. Biomed Res Int (2014) 0.75
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis (1985) 16.43
Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities. Infect Immun (1986) 8.09
Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem (1988) 5.22
Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli. Infect Immun (1985) 5.04
Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli. Infect Immun (1983) 3.85
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem (1987) 3.71
Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med (1986) 3.61
Directed lipid flow in cell membranes. Nature (1976) 3.19
Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem (1987) 3.00
Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem Biophys Res Commun (1988) 2.65
Two distinct toxins active on Vero cells from Escherichia coli O157. Lancet (1985) 2.47
Hemolytic-uremic syndrome. Current concepts and management. Pediatr Clin North Am (1982) 2.42
Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness. Proc Natl Acad Sci U S A (1976) 2.14
Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun (1988) 2.12
Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1. J Cell Biol (1989) 2.02
Verotoxin receptor glycolipid in human renal tissue. Nephron (1989) 1.88
Studies on the mechanism of membrane fusion. Role of head-group composition in calcium- and magnesium-induced fusion of mixed phospholipid vesicles. Biochim Biophys Acta (1981) 1.82
Interaction of Shigella shigae cytotoxin with receptors on sensitive and insensitive cells. J Recept Res (1980) 1.76
Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin. Proc Natl Acad Sci U S A (1977) 1.61
Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease. Int Immunol (1990) 1.45
Two-dimensional crystals of cholera toxin B-subunit-receptor complexes: projected structure at 17-A resolution. Proc Natl Acad Sci U S A (1986) 1.40
Mechanism of activation of adenylate cyclase by Vibrio cholerae enterotoxin. J Membr Biol (1975) 1.38
Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor. J Biol Chem (1987) 1.34
Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases. J Infect Dis (1989) 1.20
Pathogenesis of haemolytic uraemic syndrome. Lancet (1987) 1.12
Sulfatide-binding proteins. Chem Phys Lipids (1986) 0.86
Sulfogalactolipid binding protein SLIP 1: a conserved function for a conserved protein. J Cell Physiol (1988) 0.84
Simultaneous fractionation of four placental neutral glycosphingolipids with a continuous gradient. J Lipid Res (1989) 0.83
Unravelling HUS. Lancet (1987) 0.81
Properties and heterogeneity of human fetal pre-B cells transformed by EBV. J Immunol (1989) 0.80
MINIATURE escherichia coli CELLS DEFICIENT IN DNA. Proc Natl Acad Sci U S A (1967) 19.02
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12
Exposure measurement error in time-series studies of air pollution: concepts and consequences. Environ Health Perspect (2000) 9.30
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature (1999) 7.47
Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med (1994) 6.05
Effects of colchicine and related substances on cell division. Biochem J (1936) 5.80
Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res (2001) 5.78
Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells. Transplantation (1970) 5.37
Mouse actin messenger RNAs. Construction and characterization of a recombinant plasmid molecule containing a complementary DNA transcript of mouse alpha-actin mRNA. J Biol Chem (1981) 4.30
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature (1996) 4.04
Three cdg operons control cellular turnover of cyclic di-GMP in Acetobacter xylinum: genetic organization and occurrence of conserved domains in isoenzymes. J Bacteriol (1998) 3.81
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem (1987) 3.71
A clinical trial of active management of labor. N Engl J Med (1995) 3.34
The properties of DNA transferred to minicells during conjugation. Cold Spring Harb Symp Quant Biol (1968) 2.86
Primary cardiac valve tumors. Ann Thorac Surg (1991) 2.85
Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc Natl Acad Sci U S A (1978) 2.78
Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase. Cell (1994) 2.69
Synthesis of linear plasmid multimers in Escherichia coli K-12. J Bacteriol (1986) 2.65
Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2. Biochem Biophys Res Commun (1988) 2.65
Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group. N Engl J Med (1996) 2.55
The relationship between gastroesophageal reflux and apnea in infants. J Pediatr (2000) 2.24
A single locus in the mouse encodes both myosin light chains 1 and 3, a second locus corresponds to a related pseudogene. Cell (1984) 2.19
Postcholecystectomy biliary leaks in the laparoscopic era: risk factors, presentation, and management. McGill Gallstone Treatment Group. Gastrointest Endosc (1997) 2.15
Successful treatment of primary amebic meningoencephalitis. N Engl J Med (1982) 2.14
Percutaneous dilational tracheostomy. A bedside procedure on the intensive care unit. Anaesthesia (1991) 2.07
Management of hypertension in angiogenesis inhibitor-treated patients. Ann Oncol (2009) 2.06
Predicting relapse in Crohn's disease: a biopsychosocial model. Gut (2008) 2.01
Non-invasive diagnosis of coronary artery disease by quantitative stress echocardiography: optimal diagnostic models using off-line tissue Doppler in the MYDISE study. Eur Heart J (2003) 1.99
Central diabetes insipidus in children and young adults. N Engl J Med (2000) 1.97
Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med (1997) 1.93
The binding of Pseudomonas aeruginosa pili to glycosphingolipids is a tip-associated event involving the C-terminal region of the structural pilin subunit. Mol Microbiol (1994) 1.91
Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase. N Engl J Med (1976) 1.91
Globotetraosylceramide is recognized by the pig edema disease toxin. J Biol Chem (1989) 1.88
Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood (1989) 1.85
Quality of community drinking water and the occurrence of spontaneous abortion. Arch Environ Health (1989) 1.83
DNA isolated from Escherichia coli minicells mated with F+ cells. Proc Natl Acad Sci U S A (1968) 1.83
Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs. JAMA (2001) 1.81
Regulation of muscle gene expression. The accumulation of messenger RNAs coding for muscle-specific proteins during myogenesis in a mouse cell line. J Mol Biol (1982) 1.79
Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease. Cell (1978) 1.78
Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J Biol Chem (1983) 1.74
Experimental models for gastric leiomyosarcoma. The effects of N-methyl-N'-nitro-N-nitrosoguanidine in combination with stress, aspirin, or sodium taurocholate. Cancer (1984) 1.73
Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem (1993) 1.72
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology (2001) 1.71
Interplasmidic and intraplasmidic recombination in Escherichia coli K-12. Mol Gen Genet (1981) 1.69
Intracranial arterial dolichoectasia is associated with enlarged descending thoracic aorta. Neurology (2004) 1.69
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer (1992) 1.68
Herpesvirus hominis infection in patients with myeloproliferative and lymphoproliferative disorders. Br Med J (1972) 1.68
Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci U S A (1998) 1.68
Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol (2001) 1.67
Dynamic measurement of the pH of the Golgi complex in living cells using retrograde transport of the verotoxin receptor. J Cell Biol (1996) 1.67
Intrapartum maternal fever and neonatal outcome. Pediatrics (2000) 1.65
Protective autoimmunity is a physiological response to CNS trauma. J Neurosci (2001) 1.64
A comparison of risk factors for preterm labor and term small-for-gestational-age birth. Epidemiology (1996) 1.64
The value of magnetic resonance imaging in our current management of ACL and meniscal injuries. Knee Surg Sports Traumatol Arthrosc (2007) 1.62
Nucleotide sequence and spatial expression pattern of a drought- and abscisic Acid-induced gene of tomato. Plant Physiol (1991) 1.62
Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke (2000) 1.62
Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. J Clin Invest (1978) 1.61
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A (2000) 1.61
Plasmidic recombination in Escherichia coli K-12: the role of recF gene function. Mol Gen Genet (1983) 1.61
Myotonic heart disease: a clinical follow-up. Neurology (1991) 1.60
Noninvasive measurement of the pH of the endoplasmic reticulum at rest and during calcium release. Proc Natl Acad Sci U S A (1998) 1.59
Quality of community drinking water and the occurrence of late adverse pregnancy outcomes. Arch Environ Health (1993) 1.58
Extraction of cell-associated varicella-zoster virus DNA with triton X-100-NaCl. J Virol Methods (1982) 1.58
Three additional linkage groups that repress transcription and meiotic recombination in the mating-type region of Schizosaccharomyces pombe. Genetics (1994) 1.57
Nulliparas' preferences for epidural analgesia: their effects on actual use in labor. Birth (1999) 1.57
Outcomes of trial of labor following previous cesarean delivery among women with fetuses weighing >4000 g. Am J Obstet Gynecol (2001) 1.56
Decreased hospital utilization by older adults attributable to a home hospitalization program. J Am Geriatr Soc (1996) 1.53
Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. J Biol Chem (1991) 1.53
Guidelines on the use and monitoring of heparin. Br J Haematol (2006) 1.51
Blood-brain barrier disruption in post-traumatic epilepsy. J Neurol Neurosurg Psychiatry (2007) 1.51
Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia. Acta Haematol (1997) 1.51
Effect of nitroglycerin, intensain, isoptin and papaverine on coronary blood flow in man. Measured by the coincidence counting technic and rubidium. Am J Cardiol (1966) 1.50
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun (2007) 1.50
Chp, a homologue of the GTPase Cdc42Hs, activates the JNK pathway and is implicated in reorganizing the actin cytoskeleton. Curr Biol (1998) 1.49
Acidic pH changes receptor binding specificity of Helicobacter pylori: a binary adhesion model in which surface heat shock (stress) proteins mediate sulfatide recognition in gastric colonization. Infect Immun (1996) 1.49
A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells. Blood (1995) 1.48
Excess female mortality in India: the case of Himachal Pradesh. Am J Public Health (2000) 1.48
Properties of a cell fraction that repairs damage to the cell division mechanism of Escherichia coli. J Bacteriol (1969) 1.45
Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease. Int Immunol (1990) 1.45
Scurvy and altered iron stores in thalassemia major. N Engl J Med (1981) 1.45
Segmental tibial fractures: an assessment of procedures in 27 cases. Injury (2003) 1.44
Plasma antioxidants: evidence for a protective role against reactive oxygen species following cardiac surgery. Ann Clin Biochem (1998) 1.44
Crescentic IgA nephropathy as a manifestation of human immune deficiency virus infection. Am J Nephrol (1991) 1.44
The synthesis and stability of cytoplasmic messenger RNA during myoblast differentiation in culture. Proc Natl Acad Sci U S A (1974) 1.44
Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit. Proc Natl Acad Sci U S A (1992) 1.43
Patent foramen ovale: is stroke due to paradoxical embolism? Stroke (1993) 1.42
Genes for tryptophan biosynthesis in the archaebacterium Haloferax volcanii. Proc Natl Acad Sci U S A (1990) 1.42
Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry. J Perinatol (2008) 1.41
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. J Clin Oncol (1994) 1.41
Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg (1999) 1.41
Epidurals and cesareans: the jury is still out. Birth (1999) 1.41
Insertional mutation of the mouse Msx1 homeobox gene by an nlacZ reporter gene. Mech Dev (1997) 1.40
A multiple-dose pharmacokinetic comparison of naproxen as a once-daily controlled-release tablet and a twice-daily conventional tablet. J Clin Pharmacol (1987) 1.40
Nutrition and quality of life in the aged: the Jerusalem 70-year olds longitudinal study. Aging (Milano) (2000) 1.40
Altered mRNA binding activity and decreased translational initiation in a nuclear mutant lacking translation of the chloroplast psbA mRNA. Mol Cell Biol (1996) 1.39
Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen. Bone Marrow Transplant (2005) 1.39
Relative bioavailability of a new transdermal nitroglycerin delivery system. J Pharm Sci (1986) 1.39
Late effects of transplantation. Gerard Socie, for the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Lancet (1999) 1.39